The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

NCT02409290 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

588

Enrollment

OTHER

Sponsor class

Conditions

MDR-TB

Interventions

DRUG: Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
DRUG: Moxifloxacin
DRUG: Clofazimine
DRUG: Ethambutol
DRUG: Pyrazinamide
DRUG: Isoniazid
DRUG: Prothionamide
DRUG: Kanamycin
DRUG: Levofloxacin
DRUG: Bedaquiline

Sponsor

IUATLD, Inc

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]